Page 340 - ATP-P 11th Ed

TMEP use: Epistaxis Protocol

Phenergan – See Promethazine HCl
®
Primaquine
Description: Antimalarial
Indications: Used to prevent relapse of P. vivax and P. ovale malarias and to prevent attacks
after departure from areas where P. vivax and P. ovale malarias are endemic.
Dose: 30mg PO daily × 14 days, beginning immediately after leaving the malarious area.
• Screen for G6PD deficiency prior to dispensing.
• Give with food to prevent gastric irritation.
Contraindications:
• G6PD deficiency
• Rheumatoid arthritis
• SLE
SECTION 3 Pregnancy Category C
• Pregnancy
Side-effects:
• Darkening of urine
• Fevers
• Chills
• Cyanosis
• Nausea
• Vomiting
• Abdominal cramps
Adverse reactions:
• Visual disturbances
• Hypertension
• Anemia/leukopenia
• Methemoglobinemia
TMEP use: Malaria Protocol

®
Procardia – See Nifedipine
Promethazine HCl (Phenergan )
®
GROUNDING medication for personnel on flight status
Description: Phenothiazine class. An H receptor blocking agent. Antihistamine, sedative,
1
antimotion-sickness, antiemetic, and anticholinergic effects. The duration of action is gen-
erally from 4–6 hours. The major side-effect this drug is sedation.

330 SECTION 3 RECOMMENDED DRUG LIST (RDL)